Lv4
718 积分 2025-02-06 加入
Development of a novel humanized anti-TSLP monoclonal antibody, QX008N, and exploration of combination therapy of anti-TSLP antibody and anti-IL-4R antibody
5天前
已完结
A Novel Bispecific Antibody Targeting EGFR and cMet Is Effective against EGFR Inhibitor–Resistant Lung Tumors
19天前
已完结
Regulators of CD8+ T cell exhaustion
25天前
已完结
Ikaros degradation by mezigdomide reduces T-cell dysfunction and improves the efficacy of antimyeloma T-cell therapies
26天前
已关闭
Ruxolitinib, a novel JAK/STAT-targeted therapy through restoring mucosal homeostasis for chronic rhinosinusitis with nasal polyps
1个月前
已完结
Dual Inhibition of Interleukin-23 and Interleukin-17 Offers Superior Efficacy in Mouse Models of Autoimmunity
1个月前
已完结
P0640 Development and characterization of LQ080, a novel extended half-life bispecific TL1A/IL-23 p19 single domain antibody for the treatment of IBD
1个月前
已完结
Anti-TL1A monoclonal antibody modulates the dysregulation of Th1/Th17 cells and attenuates granuloma formation in sarcoidosis by inhibiting the PI3K/AKT signaling pathway
1个月前
已完结
Anti-IL-4R-JAKi antibody-drug conjugate effectively reduces IgE levels and inflammatory cell infiltration in Atopic Dermatitis 9245
2个月前
已完结
The Binding of CD38 Therapeutics to Red Blood Cells and Platelets Subverts Depletion of Target Cells
2个月前
已关闭
皖公网安备34019202002308
